- Home
- GWRS vs HRTX Comparison
GWRS vs HRTX Comparison
Compare GWRS & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GWRS | HRTX |
|---|---|---|
| Founded | 2003 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.9M | 228.3M |
| IPO Year | 2008 | 2007 |
Fundamental Metrics
Financial Performance| Metric | GWRS | HRTX |
|---|---|---|
| Price | $7.06 | $0.43 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $9.20 | $4.50 |
| AVG Volume (30 Days) | 135.8K | ★ 3.7M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.22% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $41,914,000.00 | ★ $154,904,000.00 |
| Revenue This Year | $15.29 | $15.28 |
| Revenue Next Year | $8.28 | $20.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.51 | 7.36 |
| 52 Week Low | $6.55 | $0.38 |
| 52 Week High | $11.17 | $2.28 |
Technical Indicators
Market Signals| Indicator | GWRS | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.18 | 33.60 |
| Support Level | $6.62 | $0.38 |
| Resistance Level | $7.81 | $0.46 |
| Average True Range (ATR) | 0.25 | 0.03 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 45.22 | 59.95 |
Price Performance
Historical ComparisonAbout GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix and Tucson, Arizona. It operates within the State of Arizona. Operating revenue of the company is derived from regulated water, wastewater, and recycled water service provided to customers based upon tariff rates.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.